MedTrace Logo

ALDOA Expression in Bladder Urothelial Carcinoma

NCT06550947 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-08-13

No results posted yet for this study

Summary

1. Study the immunohistochemical expression of ALDOA in bladder urothelial cancer.
2. Correlate between ALDOA expression in specimens and different cilnicopathological factors.
3. Correlate between ALDOA expression and urothelial cancer prognosis and survival.

Conditions

  • Bladder Urothelial Carcinoma

Interventions

GENETIC

Immunohistochemistry

Immunohistochemical expression of ALDOA in bladder urothelial carcinoma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Dalia Elsers, Professor · Head of Pathology Department

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-07-31
Completion
2025-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550947 on ClinicalTrials.gov